Hookipa Pharma
New York, US · Founded 2017 · Delaware corporation · 2 known investors
Founders & leadership
JA
Joern AldagExecutive
RK
Reinhard KanderaExecutive
PL
Paul-Henri LambertNamed on SEC filing
MK
Michael KellyNamed on SEC filing
JO
Julie O'NeillNamed on SEC filing
SV
Sander van DeventerNamed on SEC filing
Board
CL
GS
JV
Jan van de WinkelBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$37.4M disclosed across 1 round · 2019
▶$37.4MraisedFeb 2019 · 9 investors · PharmaceuticalsRule 506(b)
▶$37.4MraisedFeb 2019 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joern AldagExecutive Officer, Director
- Christoph LengauerDirector
- Paul-Henri LambertDirector
- Jan van de WinkelDirector
- Michael KellyDirector
- Reinhard KanderaExecutive Officer, Director
- Graziano SeghezziDirector
- Julie O'NeillDirector
- Sander van DeventerDirector
- Amount sold
- $37.4M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Hookipa Pharma's investors?
- Hookipa Pharma's investors include Sofinnova Partners, Third Rock Ventures.
- How much funding has Hookipa Pharma raised?
- Hookipa Pharma has disclosed $37.4M raised across 1 round.
- Where is Hookipa Pharma headquartered?
- Hookipa Pharma is headquartered in New York, US.